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In a nested case–control study of 86 cases of gastric adenocarcinoma in relation to Helicobactor pylori infection in the Korean Multi-
center Cancer Cohort, the H. pylori IgG seropositivity was 83.7% and that of the 344 matched controls was 80.8%, with a matched
odds ratio for H. pylori infection of 1.06 (95% CI, 0.80–1.40).
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In 1994, the International Agency for Research on Cancer (IARC)
classified Helicobactor pylori as a group I carcinogen (IARC, 1994),
whereas that same year, a US body concluded that there was
insufficient evidence for a causal association between H. pylori
infection and gastric adenocarcinoma (NIH Consensus Develop-
ment Panel, 1994). During the last decade, several nested case–
control studies of H. pylori infection and gastric adenocarcinoma,
including a meta-analysis (Huang et al, 1998; Danesh, 1999; Eslick
et al, 1999; Helicobacter and Cancer Collaborative Group, 2001),
were carried out. In high H. pylori infection areas, such as Eastern
Asia and Africa, the findings from epidemiological studies have
shown inconsistent results (Miwa et al, 2002; Tajima, 2002; Lunet
and Barros, 2003).
Gastric cancer is the cancer with the most frequent incidence
and is the second most common cause of cancer death in Korea
(Korea Central Cancer Registry, 2002; National Statistical Office,
2002), where the prevalence of H. pylori infection is also high. In
view of its potential importance, we carried out a nested case–
control study of the subjects in a Korean cancer cohort.
MATERIALS AND METHODS
The Korean Multi-center Cancer Cohort (KMCC) consisted of male
and female subjects aged over 30 years, who were voluntary
participants in a cancer-screening survey in four geographically
defined areas of Korea (Yoo et al, 2002). Each participant
completed a detailed questionnaire administered by trained
interviewers. In total, 10ml of blood collected was fractionated
and all the samples were stored at a temperature of  701C.
Informed consent was obtained from all the participants and the
study protocol was approved by the Institutional Review Board of
the Seoul National University Hospital and National Cancer
Center.
Cases of cancer were identified through record linkage with the
Korean Central Cancer Registry and the National Health Insurance
Cooperation database. To validate the cancer diagnosis and obtain
additional detailed clinical information, a medical record review
was undertaken for potential gastric cancer patients. Among the
10927 participants recruited between 1993 and 1999, 228
participants who had cancer prior to recruitment were excluded
from the study. Among the remaining 10699 potential study
population, 86 incident gastric cancer cases were identified. The
average time interval between the blood collection and the
diagnosis of gastric cancer was 2.6 years. Four controls from the
eligible cancer-free cohorts were matched to each cancer case by
incidence density sampling based on their age within 5 years,
gender, and the year and site of their recruitment. Thus, 86 newly
diagnosed gastric adenocarcinoma patients and 344 matched
controls were included in the final analysis.
A Genediat (Greencross Life Science) H. pylori IgG enzyme-
linked immunosorbent assay (ELISA) kit, with a sensitivity of
100% and a specificity of 81.3% in the Korean population (Eom
et al, 2001), was used to determine seropositivity of the cases and
controls according to the manufacturer’s protocol.
A multivariate conditional logistic regression model was used to
calculate the adjusted matched odds ratio (OR) and 95%
confidence intervals. Statistical analysis was performed with the
SAS v8.1 statistical package.
RESULTS
The demographic and clinical characteristics of the gastric
adenocarcinoma cases are shown in Table 1; their mean age was
63 years at recruitment and 66% of the cases were male. Most of
cases developed adenocarcinoma in the non-cardia region of the
stomach (six cardia, 70 non-cardia, one both cardia and non-
cardia, nine unspecified).
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CI, 0.88–1.67) and a history of gastritis or gastric ulcer were not
associated with increased risk (OR, 1.15; 95% CI, 0.80–1.67).
Frequent consumption of yellow–green vegetables showed a
decreased risk of gastric cancer, which was not significant (OR,
0.66; 95% CI, 0.35–1.27).
Overall, 72 (83.7%) of the 86 gastric cancer patients and
278 (80.8%) of the 344 controls were H. pylori seropositive
(Table 2). Adjustment for other variables caused little change
in the crude OR, but adjusted ORs only are reported. The matched
OR for H. pylori infection to gastric cancer was 1.06 (95% CI,
0.80–1.40), slightly greater among younger age groups (40 and 50
years), but not significantly so (OR, 1.25; 95% CI, 0.73–2.14).
There were no differences in risk between male and female
subjects or by area of recruitment. A nonsignificant increased risk
of gastric cancer associated with H. pylori positivity was observed
among subjects with more than 5 years of follow-up (OR, 1.26;
95% CI, 0.64–2.48). When cases were stratified by cancer
subsites, the risk decreased nonsignificantly (OR, 0.88; 95% CI,
0.38–2.28).
DISCUSSION
The present study suggests that there might be no direct
association between H. pylori infection and gastric adenocarcino-
ma risk in South Korea.
The confidence intervals of our study (0.80–1.40) are exclusive
of those in the meta-analysis from 12 nested case–control studies
(Helicobacter and Cancer Collaborative Group, 2001). The major
heterogeneity among the studies in the meta-analysis was from age
and time interval between sample collection and cancer diagnosis.
There was a 2.4-fold (95% CI, 1.82–3.12) increase in risk when
samples were collected less than 10 years before the diagnosis of
cancer, as were our own. A Taiwanese study, which had a median
2.0 years of follow-up showed 1.55-fold nonsignificantly increased
risk (95% CI, 0.68–3.54), whereas a Japanese study and a Chinese
study with median 3.6 years of follow-up showed 3.38 (95% CI,
1.15–9.90)- and 1.66 (95% CI, 1.08–2.54)-fold increased risk,
respectively (Webb et al, 1996; Watanabe et al, 1997; Yuan et al,
Table 1 Demographic and clinical characteristics of gastric adenocarci-
noma cases in the nested case–control study
Characteristics Categories Number (%)
Age (years) 40–59 27 (31.4)
60–69 41 (47.7)
70–82 18 (20.9)
Sex Male 57 (66.3)
Female 29 (33.7)
Areas at recruitment Haman county 50 (58.2)
Choongju city 26 (30.2)
Uljin county 5 (5.8)
Youngil county 5 (5.8)
Tumour sites Cardia 6 (7.0)
Non-cardia 70 (81.3)
Both 1 (1.2)
Unspecified 9 (10.5)
Follow-up duration o1 year 24 (27.9)
1–2 years 33 (38.4)
3–5 years 16 (18.6)
45 years 13 (15.1)
Total 86 (100.0)
Table 2 Seropositivity for Helicobacter pylori IgG antibody and adjusted matched odds ratios (ORs) for their relationship stratified by clinical characteristics
and demographics
Cases Controls
Strata Infected/total Hp
a (+), % Infected/total Hp
a (+), % Adjusted matched OR
b (95% CI)
Overall 72/86 (83.7) 278/344 (80.8) 1.06 (0.80–1.40)
Tumour sites
Cardia 4/6 (66.7) 20/24 (83.3) 0.88 (0.38–2.28)
Non-cardia 60/70 (85.7) 231/280 (82.5) 1.07 (0.77–1.49)
Follow-up duration
o1 year 21/24 (87.5) 80/96 (83.3) 1.10 (0.63–1.92)
1–3 year 27/33 (81.8) 109/132 (82.6) 1.02 (0.63–1.65)
3–5 years 12/16 (75.0) 51/64 (79.7) 0.96 (0.51–1.81)
45 years 12/13 (92.3) 38/52 (73.1) 1.26 (0.64–2.48)
Age (years)
40–59 25/27 (92.6) 88/108 (81.5) 1.25 (0.73–2.14)
60–69 33/41 (80.5) 135/164 (82.3) 0.97 (0.64–1.47)
70–82 14/18 (77.8) 55/72 (76.4) 1.03 (0.59–1.77)
Sex
Male 47/57 (82.5) 179/228 (78.5) 1.08 (0.78–1.50)
Female 25/29 (86.2) 99/116 (85.3) 1.03 (0.60–1.77)
Recruited areas
Haman county 41/50 (82.0) 159/200 (79.5) 1.05 (0.74–1.49)
Choongju city 22/26 (84.6) 85/104 (81.7) 1.06 (0.62–1.81)
Uljin county 5/5 (100.0) 18/20 (90.0) 1.03 (0.18–6.02)
Youngil county 4/5 (80.0) 16/20 (80.0) 1.06 (0.29–3.84)
aHp (+)¼Helicobacter pylori seropositivity.
bAdjusted matched OR controlling for education, alcohol consumption, and cumulative dose of smoking.
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suggested an increased risk in women with H. pylori infection
(OR, 2.6; P¼0.013), but not in men (Yatsuya et al, 2004).
Therefore, our result might be a consequence of a shorter period
between blood sampling and cancer diagnosis. However, we could
not find significant differences of ORs in different time intervals in
our data. The magnitude of the association was much greater
among subjects aged less than 60 years than among those aged 60
years or more in the meta-analysis. In our data, 69% of the patients
were aged 60 years or older; therefore, the magnitude of the
association also might be smaller than in other studies.
Two nested case–control studies conducted in Asian countries
showed less than a two-fold increased risk, and one study showed a
3.4-fold increased risk (Webb et al, 1996; Watanabe et al, 1997;
Yuan et al, 1999). In addition, a Finnish study in which the
seropositivity of the control group was greater than 80%, also
showed only a 1.5-fold nonsignificantly increased risk (Aromaa
et al, 1996). Compared with western countries, most Asian and
African countries showed higher infection rates of H. pylori, but
their gastric cancer incidence rates vary markedly, perhaps
partially explained by inaccurate data and the interactive effects
of fruits and alcohol consumption (Lunet and Barros, 2003).
The major limitations of our study are its relatively small size of
the cohort and short follow-up period, and a larger study with
longer follow-up period will be needed to confirm its findings in
this study region. The study participants were mostly farmers, so a
generalisation with respect to the entire Korean population cannot
be assumed. The disappearance of incidence of childhood infection
may have introduced temporality bias (Ohata et al, 2004). The
history of gastric ulcer or gastritis did not affect the association of
H. pylori infection to gastric cancer in our data (data not shown).
The use of serum pepsinogen as a marker of chronic gastritis could
usefully be applied in a future study.
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